•  
  •  
 

Abstract

Introduction. Increase access towards antiretroviral therapy (ART) contribute to global decrease of HIV-associated morbidity and mortality. Time to initiation of ART in eligible HIV-infected patients is associated with reduction in mortality and morbidity. Delayed initiation of antiretroviral therapy can lead to increased of mortality rate more than 10% compare to early initiation. Methods. This study was a cross sectional study among adult HIV patients in Out-patient Clinic of HIV Integrated Clinic Cipto Mangunkusumo General Hospital who started ARV therapy for the first time (ART-naïve patients) enrolled from January 2013 to December 2014. The data were extracted from medical records to identify factors associated with delayed initiation ART among HIV patient. Delayed initiation ART was defined as eligible patients didn’t initiate ART within 10 weeks after the diagnosis of HIV infection. Factors identified were gender, education level, employment, marital status, WHO clinical stage, BMI, functional status, and the presence of opportunistic infection. Logistic regression test was used to find factors associated with delayed initiation of ART. Results. There were 444 subjects in this study, which consisted of 107 patients (24.1%) who delayed initiation of ART and 337 patients (75.9%) who didn’t delayed initiation of ART. Based on the bivariate analysis, there were three variables statistically significance, which were advanced WHO clinical stage (p<0.001), lower functional status (p<0.001) and the presence of opportunistic infection (p<0.001). Further multivariate analysis showed that there were two variables associated with delayed initiation of ART, which were advanced WHO clinical stage (OR: 2.92, 95%CI 1.53-7.40, p=0.02) and the presence of opportunistic infection (OR 1.99, 95%CI 1.21-3.29, p=0.01). Conclusions. Advanced WHO clinical stage and the presence of opportunistic infections are factors associated with delayed initiation of ART among HIV patients.

References

1. Buchacz K, Baker RK, Moorman AC, et al. Rates of hospitalizations and associated diagnoses in a large multisite cohort of HIV patients in the United States, 1994–2005. AIDS. 2008;22(11):1345–54. 2. Ortblad KF, Lozano R, Murray CJL. The burden of HIV: insights from the global burden disease study 2010. AIDS. 2013;27(13):2003-17. 3. United Nations Prgramme on HIV and AIDS. Global report: UNAIDS report on global AIDS epidemic 2013 [Internet]. WHO Library Cataloguing-in-Publication Data; 2013 Nov [cited 2014 Dec 4]. 198 p. Available from: http://www.unaids.org/sites/default. 4. World Health Organization. Global update on HIV treatment 2013: results, impact, and opportunities [Internet]. Geneva: WHO Press; 2013 June [cited 2014 Nov 13]. Available from: http://www.who. int/hiv/pub/progressreports/updated2013/en. 5. World Health Organization. Abridged report: The global health sector strategy on HIV/AIDS 2011-2015: an interim review of progress, 2014 [Internet]. Geneva: WHO Press; 2014 [cited 2014 Dec 10]. Available from: http://www.who.int/hiv/amds. 6. Direktorat Jenderal Pengendalian Penyakit dan Penyehatan Lingkungan. Laporan situasi perkembangan HIV dan AIDS di Indonesia tahun 2013. Jakarta: Kementerian Kesehatan Republik Indonesia; 2013. 7. Aliyu MH, Blevins M, Parrish DD, Megazzini KM, Gebi UI, Muhammad MY, et al. Risk factor for delayed initiation of combination antiretroviral therapy in rural north central Nigeria. J Acquir Immune Defic Syndr. 2014;65(2):e41-9. 8. Zolopa AR, Andersen J, Komarow L, Sanne I, Sanchez A, Hogg E, et al. Early antiretroviral therapy reduces AIDS progression/death in individual with acute opportunistic infections: a multicenter randomized strategy trial. Plos Med. 2009;4(5):e5575. 9. Grinsztejn B, Hosseinipour MC, Ribaudo HJ, Swindells S, Eron J, Chen YQ, et al. Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial. Lancet Infect Dis. 2014;14: 281–90. 10. Simon V, Ho DD, Karim QA. HIV/AIDS epidemiology, pathogenesis, prevention, and treatment. Lancet. 2006;368(9534):489-504. 11. Alvarez-Uria G, Pakam R, Midde M, Naik PK. Predictors of Delayed Antiretroviral Therapy Initiation, Mortality, and Loss to Followup in HIV Infected Patients Eligible for HIV Treatment: Data from an HIV Cohort Study in India. Biomed Res Int. 2013;2013:1-10. 12. Indonesia Ministry of Health. Cases of HIV/AIDS in Indonesia. Jakarta: Kemenkes RI; 2014 Sept [cited 2015 June 5]. Available from: http://www.spiritia.or.id/Stats/StatCurr.pdf 13. Liu E, Spiegelman D, Semu H, Hawkins C, Chalamilla G, Aveika A, et al. Nutritional Status and Mortality Among HIV- Infected Patients Receiving Antiretroviral Therapy in Tanzania. J Infect Dis. 2011;204(282):282–90. 14. Sinha S, Shekhar RC, Singh G, Shah N, Ahmad H, Kumar N, et al. Early versus Delayed Initiation of Antiretroviral Therapy for Indian HIV-Infected Individuals with Tuberculosis on Antituberculosis Treatment. BMC Infect Dis. 2012;12(168):1-9. 15. Vidrine DJ, Amick BC, Gritz ER, Arduino RC. Functional Status and Overall Quality of Life in a Multiethnic HIV-Positive Population. AIDS Patient Care STDS. 2003;17(4):187-97. 16. Kaplan JE, Hanson D, Dworkin MS, Frederick T, Bertolli J, Lindergren ML, et al. Epidemiology of Human Immunodeficiency Virus-Associated Opportunistic Infections in the United States in the Era of Highly Active Antiretroviral Therapy. Clin Infect Dis. 2000;30(Suppl1):S5-14. 17. Chakraborty Nilanjan, Mukerjee A, Santra S, Sarkar RN, Banerjee D, Guha K, et al. Current Trends of Oprtunistic Infections among HIV-Serppositive Patients from Eastern India. Jpn J Infect Dis. 2008;61(1):49-53. 18. Mishra BN, Sinha ND, Shukla SK, Das RN. The Epidemiology of Opportunistic Infection in HIV/AIDS Cases in Nepal. Indian J Prev. Soc Med. 2009;40(1):96-100. 19. Rubaihayo J, Tumwesigye NM, Konde-Lule J. Trends in Prevalence of Selected Opportunistic Infections Associated with HIV/AIDS in Uganda. BMC Infect Dis. 2015;15:187. 20. Chilton D, Edwards SG, Pallegrino P, Miller RF. Factors Influencing Delay in Initiating Antiretroviral Therapy Among HIV infected patients Coinfected with Tuberculosis. Thorax. 2008;63(10):935-6. 21. Kementerian Kesehatan Republik Indonesia. Pedoman tatalaksana infeksi HIV dan terapi antiretroviral di Indonesia. Jakarta: Peraturan Pemerintah Kementerian Kesehatan Republik Indonesia; 2014. 22. World Health Organization. Tuberculosis care with TB-HIV comanagement 2007 [Internet]. Geneva: WHO Press; 2007 [cited 2015 Jan 20]. Available from: http://www.who.int/hiv/pub/imai/ TB_HIVmodule 23. Mendelson M. Diagnosing tuberculosis in HIV-infected patients: challesnges and future prospects. Br Med Bull. 2007; 81(1):1-6. 24. Naidoo K, Baxter C, Karim SSA. When to start Antiretroviral therapy during Tuberculosis ttreatment? Curr Opin in Infect Dis. 2013;26(1):35–42.

Download

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.